ARAGONA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 662
AS - Asia 494
EU - Europa 375
SA - Sud America 72
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.631
Nazione #
US - Stati Uniti d'America 650
SG - Singapore 195
DE - Germania 124
CN - Cina 114
VN - Vietnam 85
BR - Brasile 53
IE - Irlanda 47
SE - Svezia 47
FI - Finlandia 43
IT - Italia 43
HK - Hong Kong 31
ZA - Sudafrica 21
FR - Francia 15
NL - Olanda 15
GB - Regno Unito 13
IN - India 12
BD - Bangladesh 11
TR - Turchia 9
AR - Argentina 6
PL - Polonia 6
AT - Austria 5
CA - Canada 4
MX - Messico 4
PK - Pakistan 4
SA - Arabia Saudita 4
BE - Belgio 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IQ - Iraq 3
JP - Giappone 3
MY - Malesia 3
PH - Filippine 3
AL - Albania 2
BG - Bulgaria 2
CO - Colombia 2
CR - Costa Rica 2
ES - Italia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
MA - Marocco 2
PE - Perù 2
PY - Paraguay 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
RU - Federazione Russa 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.631
Città #
Ashburn 128
Munich 114
Singapore 98
Dallas 92
Chandler 80
San Jose 49
Dublin 47
Santa Clara 47
Helsinki 39
Beijing 35
Hong Kong 30
Ho Chi Minh City 28
Hanoi 23
Johannesburg 21
Shanghai 20
Boardman 19
New York 15
Lauterbourg 13
Los Angeles 13
Nanjing 12
Buffalo 10
Izmir 7
London 7
Princeton 7
São Paulo 7
Parma 6
Pune 6
Columbus 5
Vienna 5
Warsaw 5
Wilmington 5
Ann Arbor 4
Bremen 4
Dearborn 4
Naples 4
Nuremberg 4
San Mateo 4
Bologna 3
Brussels 3
Calenzano 3
Changsha 3
Dammam 3
Denver 3
Kuala Lumpur 3
Marnate 3
Mumbai 3
Ningbo 3
Norwalk 3
Orem 3
Rio de Janeiro 3
San Francisco 3
Shenyang 3
Tianjin 3
Amman 2
Atlanta 2
Buenos Aires 2
Can Tho 2
Chicago 2
Cremona 2
Da Nang 2
Dhaka 2
Frankfurt am Main 2
Haiphong 2
Itabuna 2
Jyväskylä 2
Kunming 2
Lima 2
Nanchang 2
Phoenix 2
Quận Hai 2
Seattle 2
Sofia 2
Tokyo 2
Turku 2
Abidjan 1
Alajuela 1
Amsterdam 1
Américo Brasiliense 1
Andover 1
Andrews 1
Arraial do Cabo 1
Arroio Grande 1
Baghdad 1
Baku 1
Bandar Seri Begawan 1
Bangkok 1
Bari 1
Barra Mansa 1
Belo Horizonte 1
Belém 1
Bethesda 1
Bishkek 1
Biên Hòa 1
Borgia 1
Boston 1
Bragança Paulista 1
Brasília 1
Bullhead City 1
Burlington 1
Bắc Giang 1
Totale 1.133
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 279
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 160
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 147
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: Results from a large Italian cohort study 138
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 127
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 107
One-week H. Pylori eradication therapy Rabeprezole 20 mg bid vs 10 mg bid 107
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 102
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 101
The management of endoscopic retrograde cholangiopancreatography- related infections risk: results of an italian survey at regional level 96
Spyglass percutaneous transhepatic lithotripsy of symptomatic recurrent lithiasis of the intrahepatic bile duct with distal stenosis 87
Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 87
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 75
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 32
Totale 1.645
Categoria #
all - tutte 5.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.767


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202244 1 1 0 1 4 0 5 0 4 3 5 20
2022/2023219 14 24 18 23 12 27 1 20 68 5 6 1
2023/2024118 6 10 8 5 10 19 11 23 2 6 8 10
2024/2025446 14 15 13 14 45 73 65 37 68 22 29 51
2025/2026742 80 45 119 81 121 45 62 27 73 52 34 3
Totale 1.645